Sorafenib

ADAM metallopeptidase domain 9 ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32245188 A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy. 2020 Mar 21 2
2 21530512 microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma. 2011 Jun 23 3
3 20099300 Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9. 2010 Apr 3